Skip to main content

Pembrolizumab-axitinib nearly halves risk of death in RCC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Pembrolizumab-axitinib nearly halves risk of death in RCC

User login

Username

Password

Reset your password

Type	Lead	score